Abtak Logo

oligonucleotide News

Stay updated with the latest oligonucleotide news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on oligonucleotide topics.

Abtak.com - Business - News Image
soure image
31
BusinessOct 28, 2025 12:34 PM

Sai Life Sciences to unveil new R&D facility in Sept 2026 - CNBC TV18

The investment is part of the company's planned capital expenditure, reflecting strong business momentum, a robust late-stage development pipeline, and increasing demand for scalable capacity across CMC development and manufacturing. Sai Life Sciences Ltd. on Monday, October 27, announced that it is setting up a new research and development (R&D) block for chemical, manufacturing, and controls processing Hyderabad campus. The five-storeyed facility, designed as a green building, is expected to ...Read More >

The Times of India - Other Sports Environment Entertainment Business Politics - News Image
soure image
23

Traffic likely to be affected in central Delhi areas today | Delhi News - Times of India

New Delhi: Traffic in central Delhi will be affected on Thursday as the traffic police has issued an advisory due to the Janmashtami and Tazia processions.According to police, the traffic movement in Paharganj is likely to be affected from 1.30pm in view of the shobha yatra for Janmashtami and the Tazia procession.The Janmashtami procession will start from Mandir Shri Banke Bihari Ji in Paharganj's Sangatrasan Bazar and pass through Desh Bandhu Gupta Road, Chuna Mandi, Main Bazar, Munja Chowk an ...Read More >

Unknown Source - Business - News Image
source image
14
BusinessAug 14, 2025 12:50 AM

Cohance Lifesciences to invest ₹23 cr in a new facility in Hyderabad

Cohance Lifesciences will be investing ₹23 crore (₹230 million) in its new Current Good Manufacturing Practice (cGMP) oligonucleotide building block manufacturing facility in Hyderabad. "Oligonucleotides are a fast-emerging therapeutic class, and innovators are seeking integrated, cost-efficient partners with scalable GMP capacity. This facility is a high-impact strategic investment that complements our pilot and scale-up assets, positioning Cohance to deliver with speed, quality and flexibi ...Read More >

The Times of India - Business - News Image
soure image
18
BusinessAug 14, 2025 12:38 AM

Cohance to invest Rs 110 crore in new facilities in Hyderabad and New Jersey | Hyderabad News - Time...

Hyderabad: Cohance Lifesciences Limited, backed by PE giant Advent International, is investing Rs 110 crore in its facilities in Hyderabad and New Jersey. This includes $10 million (approx. Rs 87 crore) in expanding its cGMP bioconjugation capabilities at its US-based subsidiary, NJ Bio, and Rs 23 crore in its new cGMP oligonucleotide building block manufacturing facility in Hyderabad.The new facility in Hyderabad, Cohance said, will enable it to take high-value chemistries like modified nucleos ...Read More >

Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.